GT Medical Technologies Announces First Patient Enrolled in GESTALT Trial of GammaTile(R) Therapy for Newly Diagnosed Glioblastoma Brain Tumors

This phase 4 clinical trial evaluates the use of GammaTile Therapy at the time of surgery combined with the standard Stupp protocol for patients with newly diagnosed glioblastomas. TEMPE, Ariz., Oct. 11, 2022 -- (Healthcare Sales & Marketing Network) -... Devices, Oncology, Neurosurgery GT Medical Technologies, GammaTile, Surgically Targeted Radiation Therapy
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news